 |
Summary of Study Results
Prostate Cancer and PCBs
(Each entry represents one finding in the 22 studies unless otherwise
noted. Some studies had multiple findings.)
-
PCBs increased prostate size at a dosage consumed by the general public
-
permanently increased androgen receptor (AR) binding activity of the prostate
at a dosage consumed by the general public
-
induced prostate growth in the presence and absence of testosterone; however,
it was more effective in the presence of testosterone
-
estrogenic chemicals [such as PCBs] induce reproductive malformation by
direct interference with the fetal reproductive organs
-
PCBs are able to induce malformation even in the absence of fetal testosterone;
however, they are more effective in the presence of testosterone
-
PCB 169 resulted in abnormal rodent sex differentiation
-
the developing animal is extremely sensitive to toxicants during sex differentiation
-
many effects are difficult to detect until late in life
-
ventral prostate weight was reduced by PCB 126 and especially PCB 105
-
PCB 105 affects development of the male reproductive system by mechanisms
in addition to or independent of Ah receptor agonist activity
-
ventral prostate (VP) weight was reduced by 36% in the PCB group
-
myeloperoxidase (MPO) activity in the lateral prostate (a measure of inflammation)
was higher
-
An association was suggested between PCB concentrations in subcutaneous
abdominal adipose tissue and the occurrence of prostate cancer
-
PCBs increased enzyme activities in rat prostates, in a more pronounced
fashion than other inducing chemicals
-
prostate sensitivity to PCB enzyme induction and the capacity of the prostate
to produce mutagenic metabolites might be of importance for initiation
of prostatic cancer by environmental factors.
-
PCB metabolites [breakdown products] have been found in the ventral prostate
-
prostate weights (g) were slightly increased in the PC60 group at the 1st
and 4th week following treatment
-
ventral prostate weights permanently reduced in PCB 126 treated male rats
-
Ventral prostate weights in all experimental male offspring were significantly
less than those of controls
-
Low but detectable amounts of PCB metabolites were found in cytosolic preparations
from prostate
-
furans significantly decreased ventral prostate weights [PCBs are generally
contaminated with furans]
-
furans are more toxic substances than PCBs when administered to rats
-
PCB-126 had no effect on the androgen receptor content of the prostate
-
dioxin enhanced AHH enzyme activity in the prostate [PCBs are frequently
contaminated with dioxins]
-
the effects of PCB 169 bear little resemblance to those of any known anti-androgen
-
endocrine disrupting chemicals [such as PCBs] operate during critical period
(s) in the early stage of life characterized by rapid cell differentiation
and organogenesis, leaving irreversible disruption
-
endocrine disrupting chemicals [such as PCBs] may not demonstrate any clear
minimum threshold in exerting their "toxicological" effects
-
endocrine disrupting chemicals [such as PCBs] may act synergistically or
additively with other chemicals
-
firefighters face increased prostate cancer risks, after chemical exposures
which often include PCBs and furans
-
prostate cells were used to test endocrine disrupting chemicals, such as
PCBs
-
disturbed male sexual differentiation may in some cases be caused by increased
exposure to environmental xenoestrogens and/or antiandrogens [such as PCBs]
-
PCBs are metabolically activated to electrophilic quinoid species capable
of binding to DNA
-
PCB metabolites are capable of redox cycling, thereby increasing oxidative
stress in biological systems
-
PCB congeners form DNA adducts after metabolic activation
-
this study could not detect PCB DNA effects in live rats
-
PCBs may be a key factor in prostate cancer
-
PCBs dramatically increased certain steroid hormones (but not others) in
rat prostate tissues
-
cancer risk is higher for people born during the 1950s than for those born
in 1873-82
-
men face a cancer risk three times higher than before
-
human prostate cell lines may be targeted by PCBs for changes in proliferation,
migration and growth factor gene expression, which may be mechanisms for
the promotion of prostate disease
-
both genetic and environmental factors may contribute to the racial differential
in both incidence and mortality of prostate cancer among blacks and whites
-
gene-environmental interactions initiate and promote prostatic neoplasia
[prostate cancer]
|